Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fine-tuning of type I IFN-signaling in microglia - implications for homeostasis, CNS autoimmunity and interferonopathies.
Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.
Natalizumab reduces relapse clinical severity and improves relapse recovery in MS.
Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.
Functional brain imaging: an evidence-based analysis.
Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D.
Oral BG-12 in multiple sclerosis.
Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography.
Control of IL-17 receptor signaling and tissue inflammation by the p38α-MKP-1 signaling axis in a mouse model of multiple sclerosis.
Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images.
Thiopalmitoylation of Altered Peptide Ligands Enhances Their Protective Effects in an Animal Model of Multiple Sclerosis.
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us?
Interferon beta-1a for multiple sclerosis: old drug, new clothes.
Sexual function in women with multiple sclerosis.
Sexual dysfunction in women with multiple sclerosis: Dimensions and contributory factors.
Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.
Bone Marrow-Derived Stem Cells and Strategies for Treatment of Nervous System Disorders: Many Protocols, and Many Results.
[Vitamin D and neurology.]
Comparison of the Effect of 8 weeks Aerobic and Yoga Training on Ambulatory Function, Fatigue and Mood Status in MS Patients.
Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice.
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.
Efficacy of A Telephone-Delivered Self-Management Intervention For Persons With Multiple Sclerosis: a Randomized Controlled Trial With a One-Year Follow-Up.
The Fc Receptor-Like 3 Polymorphisms (rs7528684, rs945635, rs3761959 and rs2282284) and The Risk of Neuromyelitis Optica in A Chinese Population.
Tumefactive demyelination presenting during bevacizumab treatment.

Pages